A
ALK-Abelló A/S (AKBLF)
PNK – Real vaqt narxi. Valyuta: USD
37.91
0.00 (0.00%)
Yopilishda: Sep 7, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
PNK – Real vaqt narxi. Valyuta: USD
37.91
0.00 (0.00%)
Yopilishda: Sep 7, 2026, 4:00 PM EDT
ALK-Abelló A/S, allergiya yechimlari kompaniyasi, Yevropa Ittifoqi, Buyuk Britaniya, Norvegiya, Shveysariya, Qo'shma Shtatlar, Kanada, Yaponiya, Xitoy va xalqaro miqyosda respirator allergiyasi, anafilaksiya va oziq-ovqat allergiyasi uchun davolash usullarini va yangi kasallik sohalarini ishlab chiqadi. Kompaniya turli allergiyalarni, shu jumladan, o't va daraxt gul changi, uy changi kenasi, ambroziya, yapon kedri, yong'oq va daraxt yong'oqlari uchun vaktsinalar, in'ektsiyalar, sublingual tomchilar va tabletkalarda allergiya immunoterapiyasi mahsulotlarini taklif etadi; anafilaksiya va surunkali spontan eshakemiya o'tkir xurujlarini shoshilinch davolash uchun adrenalin burun spreylari; va oziq-ovqat allergiyalari uchun biologik preparat bo'lgan ALK 014. U, shuningdek, o't gul changi allergiyasi uchun tabletka bo'lgan GRAZAX/GRASTEK; uy changi kenasi allergiyalari uchun tabletka bo'lgan ACARIZAX, ODACTRA va MITICURE/SENSIMUNE; daraxt gul changi allergiyasi uchun tabletka bo'lgan ITULAZAX/ITULATEK; ambroziya gul changi allergiyasi uchun tabletka bo'lgan RAGWITEK/RAGWIZAX; va yapon kedri allergiyasi uchun tabletka bo'lgan CEDARCURE ni taqdim etadi. Bundan tashqari, kompaniya foydalanuvchilarning o'z allergiyalarini boshqarishga yordam beradigan raqamli bemorlarni jalb qilish platformasi bo'lgan klarify.me kabi iste'molchi salomatlik yechimlarini taklif etadi. Shuningdek, u teri sanchish va qon tekshiruvi kabi o'ziga xos allergiyalarni tashxislash uchun ishlatiladigan allergen ekstraktlarini; va anafilaksiya, shu jumladan, o'tkir hayot uchun xavfli allergik reaktsiyalarni davolash uchun adrenalinning mushak ichiga in'ektsiyasi bo'lgan adrenalin avtoin'ektorlari kabi shoshilinch tibbiy davolashni taqdim etadi. Kompaniya GRAZAX va CEDARCUREni ishlab chiqish bo'yicha Torii Pharmaceutical Co., Ltd. bilan hamkorlik qiladi; va Sensimune'ni ishlab chiqish bo'yicha Dr. Reddy's Laboratories bilan hamkorlik qiladi. ALK-Abelló A/S 1923 yilda tashkil etilgan va shtab-kvartirasi Daniyaning Xorsholm shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Claus Steensen Solje | Executive VP, CFO & Member of Management Board |
| Mr. Johan Smedsrud | Senior Maintenance Supporter of Process & Production Support & Employee Representative Director |
| Mr. Per Plotnikof | VP of Corporate Communications, Investor Relations & Strategic Planning and Head of IR |
| Mr. Peter Halling | President, CEO & Member of Management Board |
| Mr. Søren Daniel Niegel | Member of Management Board |
| Ms. Katja Barnkob Thalund | Senior Project Director, Global Clinical Development & Employee-elected Director |
There is no data to display
| Ms. Lika Thiesen | Executive Vice President of Global People & Organisation |
| Ms. Lise Lund Maerkedahl | Project Director of Global Clinical Development & Employee-elected Director |
| Ms. Nanna Rassov Carlson | Senior Manager of QA Release & Employee Representative Director |
| Prof. Hendrik Kees Kam Nolte M.D., Ph.D. | Senior Vice President of Research & Development - North America and International Markets |